HALO Halozyme Therapeutics, Inc.

93.04USD-2.88%Mkt Cap: 10.61B USDP/E: 23.26

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's …